Alexánderson RE, Ortega LN, Ojeda FR, Mendoza VG, Adame OG, Meave GA, Saldaña DY, Lamothe MPA, Rodríguez VM, García RCL, Narro RJ

Language: Spanish
References: 33
Page: 11-18
PDF size: 208.33 Kb.

ABSTRACT

Purpouse: To standarize an acquisition protocol for the study of myocardial metabolism in adult rats. Material and methods: Three Wistar adult male rats were studied in three different protocols: no fasting group, fasting group over a period of 12 hr before the study with only water provided ad libitum, and fasting group by the same time receiving an oral 50% glucose solution. Thirty-minute acquisition images were obtained with a micro-PET, thirty and sixty minutes after the administration of 370 - 555 MBq 18F-FDG. Comparative and visual analysis were performed by two experts in the field. Results: Eigtheen studies were analyzed, six per group. The best images were those of the fist group, especially those taken at 60 minutes after the 18F-FDG administration. Conclusion: It is possible to establish the non-fasting protocol for the assessment of myocardial metabolism to be used in the future for the myocardial viability evaluation in ischemic cardiopathy.

REFERENCES

1. World Health Organization. Página Web disponible en: http://www.who.int/cardiovascular_diseases/prevention_control/en/

2. Instituto Nacional de Estadística, Geografía e Informática. Página Web disponible en: http://www.inegi.gob.mx/est/default.aspx?c=2346

3. Lefebvre C, Chênevert A, Bordeleau E, Ugolini P, Ouellet R, Sablayrolles J, et a: Coronary computed tomography angiography: overview of technical aspects, current concepts, and perspectives. Can Assoc Radiol J 2007; 58: 92-108.

4. Lombardo A, Rizzello V, Galiuto L, Natale L, Giordano A, Rebuzzi A, et al: Assessment of resting perfusion defects in patients with acute myocardial infarction: comparison of myocardial contrast echocardiography, combined first-pass/delayed contrast-enhanced magnetic resonance imaging and 99mTC-sestamibi SPECT. Int J Cardiovasc Imaging 2006; 22: 417-28.

5. Klein L, van Campen L, Sieswerda G, Kamp O, Visser C, Visser F: Glucose-insulin-potassium echocardiography detects improved segmental myocardial function and viable tissue shortly after acute myocardial infarction. J Am Soc Echocardiogr 2006; 19: 763-71.

6. Ropers D: Multislice computer tomography for detection of coronary artery disease. J Interv Cardiol 2006; 19: 574-82.

7. Nikolaou K, Flohr T, Knez A, Rist C, Wintersperger B, Johnson T, et al: Advances in cardiac CT imaging: 64-slice scanner. Int J Cardiovasc Imaging. 2004; 20: 535-40.

8. Beanlands R, Dekemp R, Scheffel A, Nahmias C, Garnett S, Coates G: Can Nitrogen-13 Ammonia Kinetic Modeling Define Myocardial Viability Independent of Fluorine-18 Fluorodeoxyglucose? J Am Coll Cardiol 1997; 29: 537-43.

9. Slart R, Bax J, de Boer J, Willemsen A, Mook P, Oudkerk M, et al: Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction. Eur J Nucl Med Mol Imaging 2005; 32: 972-9.

10. Roelants V, Bernard X, Walrand S, Bol A, Coppens A, Jamart J, el al: Attenuation-corrected 99mTc-MIBI SPECT in overweight patients with chronic ischaemic dysfunction: a comparison to NH3 PET and implications for the diagnosis of myocardial viability. Nucl Med Commun 2006; 27: 815-21.

11. Meave A, Ricalde A, Sierra C F, García L, Alexánderson E: Estudio de la viabilidad miocárdica: Comparación de tomografía por emisión de positrones y resonancia magnética. Arch Cardiol Mex 2005; 75: 71-78.

12. Brodoefel H, Reimann A, Klumpp B, Fenchel M, Ohmer M, Miller S, et al: Assessment of myocardial viability in a reperfused porcine model: evaluation of different MSCT contrast protocols in acute and subacute infarct stages in comparison with MRI. J Comput Assist Tomogr 2007; 31: 290-8.

13. Goldfarb J, Arnold S, Roth M, Han J: T1-weighted magnetic resonance imaging shows fatty deposition after myocardial infarction. Magn Reson Med 2007; 57: 828-34.

14. Surányi P, Kiss P, Brott B, Simor T, Elgavish A, Ruzsics B, et al: Percent infarct mapping: an R1-map-based CE-MRI method for determining myocardial viability distribution. Magn Reson Med 2006; 56: 535-45.

15. Maki M, Haaparanta M, Nuutila P, Oikonen V, Luotolahti M, Eskola o, et al: Free fatty acid uptake in the myocardium and skeletal muscle using fluorine-18 fluoro-6-thia-heptadecanoic acid. J Nucl Med 1998; 39: 320-7.

16. Visser F: Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate. Coron Artery Dis 2001; 12: S12-8.

17. Alexanderson E, Gómez M, Benito I, Ruiz R, Ricalde A, Meave A: Tomografía por emisión de positrones (PET): Una herramienta útil para el estudio del metabolismo cardíaco. Arch Cardiol Mex 2004; 74: 220-28.

18. Schelbert H, Beanlands R, Bengel F, Knuuti J, Di Carli M, Machac J, et al: Pet myocardial perfusion and glucose metabolism imaging: part 2-guidelines for interpretation and reporting. J Nucl Cardiol 2003; 10: 557-71.

19. Alexánderson E: Utilidad de las técnicas nucleares en el estudio de la viabilidad miocárdica. Arch Cardiol Mex 2004; 74: 8-12.

20. Strauss HW, Grewal RK, Taskar NP: Molecular Imaging in Nuclear Cardiology. Semin Nucl Med 2004; 34: 47-55.

21. Meoli D, Sadeghi M, Krassilnikova S, Bourke B, Giordano F, Dione D, et al: Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest 2004; 113: 1684-91.

22. Sokolova RI, Zhdanov VS: Hibernation and stunning as manifestations of ischemic dysfunction of the myocardium. Arkh Patol 2002; 64: 50-4.

23. Wu J, Inubushi M, Sundaresan G, Schelbert H, Gambhir S: Positron emission tomography imaging of cardiac reporter gene expression in living rats. Circulation 2002; 106: 180-3.

24. Inubushi M, Wu J, Gambhir S, Sundaresan G, Satyamurthy N, Namavari M et al: Positron-emission tomography reporter gene expression imaging in rat myocardium. Circulation 2003; 107: 326-32.

25. Kudo T, Annata A, Cherry S, Phelps M, Schelbert H: Measurement of myocardial blood flow during occlusion/reperfusion in rats with dynamic microPET imaging. J Nucl Med 1998; 39: 9P.

26. Lapointe D, Bentourkia M, Cadorette J, Rodrigue S, Ouellet R, Bernard F, et al: High-resolution cardiac PET in rats. J Nucl Med 1999; 40: 185P.

27. Kreissl M, Wu H, Stout D, Ladno W, Schindler T, Zhang X, et al: Noninvasive measurement of cardiovascular function in mice with high-temporal-resolution small-animal PET. J Nucl Med 2006; 47: 974-80.

28. microPET__Siemens Focus 120 and 220. Siemens Medical Solutions USA, Inc. 2005.

29. Fueger B, Czernin J, Hildebrandt I, Tran C, Halpern B, Stout D, et al: Impact of Animal Handling on the Results of 18F-FDG PET Studies in Mice. J Nucl Med 2006; 47: 999-1006.

30. Gould K, Schelbert H, Phelps M, Hoffman E: Non invasive assesment of coronary stenoses with myocardial perfusion imaging during pharmacologic coronary vasodilatation. Am J Cardiol 1979; 43: 200-208.

31. Sochor H, Pachinger O, Orgis E, Probst P, Kaindl F: Radionuclide imaging alter coronary vasodilatation: myocardial scintigraphy with thallium-201 and radionuclide angiography alter administration of dipyridamole. Eur Heart J 1984; 5: 500-9.

32. Santalucia T, Camps M, Castello A, Munoz P, Nuel A, Testar X, et al: Developmental regulation of GLUT-1 (erythroid/Hep G2) and GLUT-4 (muscle/fat) glucose transporter expression in rat heart, skeletal muscle, and brown adipose tissue. Endocrinology 1992; 130: 837-46.

33. Baxx J, Veening M, Visser F, van Lingen A, Heine R, Cornel L, et al: Optimal metabolic conditions during Fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols. Eur J Nucl Med 1997; 24: 35-41.